NEW YORK (360Dx) – Immucor  announced on Monday that the US Food and Drug Administration has cleared the company's Echo Lumena instrument for donor-patient blood matching.

The instrument is Immucor's fifth-generation immunohematology instrument, and with the fully automated NEO platform, they offer a standardized workflow solution for laboratories. Immucor added that with its data management solution, ImmuLink, labs will be able to combine serology and molecular immunohematology results into one view, improving their productivity.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.